SCHEMBL7012509

SCHEMBL7012509

NC1(c2c(F)c(F)c(F)c3[nH]cc(C(=O)O)c(=O)c23)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A1 P68400 5/20 0.41
▸ CSNK2A2 P19784 4/20 0.41
▸ CSNK2B P67870 4/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ KDM4E B2RXH2 3/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ PIM3 Q86V86 3/20 0.35
▸ RPS6KB1 P23443 1/20 0.35
▸ MATK P42679 1/20 0.35
▸ DYRK1A Q13627 1/20 0.35
▸ MAPKAPK3 Q16644 1/20 0.35
▸ AURKB Q96GD4 1/20 0.35
▸ DNA2 P51530 1/20 0.35
▸ CASP6 P55212 1/20 0.35
▸ CTDSP1 Q9GZU7 1/20 0.35
▸ CLK4 Q9HAZ1 1/20 0.35
▸ KMT2A Q03164 1/20 0.33
▸ GSK3B P49841 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9540878 0.86 GSK3B (0.44) CSNK2A1CSNK2A2CSNK2BCYP1A2HSD17B10
SCHEMBL9426359 0.82 PIM3 (0.38) CSNK2A1CSNK2A2CSNK2BCYP1A2HSD17B10
SCHEMBL7499500 0.82 PIM3 (0.36) CSNK2A1CSNK2A2CSNK2BCYP1A2HSD17B10
SCHEMBL10771039 0.81 KDM4E (0.38) CSNK2A1CSNK2A2CSNK2BCYP1A2HSD17B10
Hydrochloric Acid SCHEMBL10769201 0.81 PIM3 (0.36) CSNK2A1CSNK2A2CSNK2BCYP1A2HSD17B10
SCHEMBL10508264 0.80 CSNK2A1 (0.51) CSNK2A1CSNK2A2CSNK2BCYP1A2HSD17B10
SCHEMBL8937193 0.80 KMT2A (0.50) CSNK2A1CSNK2A2CSNK2BCYP1A2HSD17B10
SCHEMBL10766998 0.79 PIM3 (0.36) CSNK2A1CSNK2A2CSNK2BCYP1A2HSD17B10
SCHEMBL7011704 0.78 PRKAB2 (0.34) CSNK2A1CSNK2A2CSNK2BCYP1A2HSD17B10
SCHEMBL10769436 0.77 KDM4E (0.44) CSNK2A1CSNK2A2CSNK2BCYP1A2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-11060578-A — — None — — JP disclosed
JP-5112554-A — — None — — JP disclosed
EP-1187835-A4 OPTICALLY ACTIVE QUINOLINE CARBOXYLIC ACID DERIVATIVES HAVING 7-PYRROLIDINE SUBSTITUTES CAUSING OPTICAL ACTIVITY AND A PROCESS FOR PREPARING THEREOF DONG WHA PHARM IND CO LTD (KR) 2003-01-29 — — EP disclosed
EP-1187835-A1 OPTICALLY ACTIVE QUINOLINE CARBOXYLIC ACID DERIVATIVES HAVING 7-PYRROLIDINE SUBSTITUTES CAUSING OPTICAL ACTIVITY AND A PROCESS FOR PREPARING THEREOF DONG WHA PHARMACEUTICAL INDUSTRIAL CO. LTD. (KR) 2002-03-20 — — EP disclosed
WO-2000071541-A1 OPTICALLY ACTIVE QUINOLINE CARBOXYLIC ACID DERIVATIVES HAVING 7-PYRROLIDINE SUBSTITUTES CAUSING OPTICAL ACTIVITY AND A PROCESS FOR PREPARING THEREOF DONG WHA PHARM. IND. CO., LTD. (KR) 2000-11-30 — — WO disclosed
EP-0561850-B1 7-SUBSTITUTED-6-FLUORO-1,4-DIHYDRO-4-OXO-QUINOLINE-3-CARBOXYLIC ACID COMPOUNDS USEFUL AS ANTIBACTERIAL AGENTS NAEJA PHARMACEUTICAL INC (CA) 2000-07-12 — — EP disclosed
JP-H1160578-A PYRIDONECARBOXYLIC ACID DERIVATIVE, ESTER THEREOF OR SALT THEREOF DAINIPPON PHARMACEUT CO LTD 1999-03-02 — — JP disclosed
EP-0559774-A1 INDIVIDUAL STEREOISOMERS OF 7- 3-(1-AMINOALKYL)-1-PYRROLIDINYL]-QUINOLONES AND NAPHTHYRIDONES AS ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 1993-09-15 — — EP disclosed
US-5221676-A 7-substituted quinolones and naphthyridones as antibacterial agents WARNER-LAMBERT COMPANY (US) 1993-06-22 — — US disclosed
JP-H05112554-A NEW QUINOLONECARBOXYLIC ACID DERIVATIVE CHUGAI PHARMACEUT CO LTD 1993-05-07 — — JP disclosed
EP-0242789-A2 Novel quinoline derivates and processes for preparation thereof Dainippon Pharmaceutical Co., Ltd. (JP) 1987-10-28 — — EP disclosed
EP-0221463-A2 Quinoline derivatives and processes for preparation thereof Dainippon Pharmaceutical Co., Ltd. (JP) 1987-05-13 — — EP disclosed
Send feedback